These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5330801)

  • 1. Present status of the concept of oxygen differential in the etiology of ventricular fibrillation after coronary occlusion.
    Badeer HS
    Am Heart J; 1966 Aug; 72(2):238-41. PubMed ID: 5330801
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the genesis of ventricular fibrillation in the course of a temporary occlusion of the coronary artery. II.
    Wojtowicz M; Dybicki J; Zawistowski S; Wrzolek S; Bartoszewicz T
    Pol Med J; 1967; 6(2):479-81. PubMed ID: 6030655
    [No Abstract]   [Full Text] [Related]  

  • 3. Derangements of myocardial metabolism preceding onset of ventricular fibrilliation after coronary occlusion.
    Corday E; Heng MK; Meerbaum S; Lang TW; Farcot JC; Osher J; Hashimoto K
    Am J Cardiol; 1977 May; 39(6):880-9. PubMed ID: 16479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular fibrillation after acute coronary artery occlusion. An experimental study.
    Pifarré R; Yokoyama T; Ilano AC; Hufnagel CA
    J Thorac Cardiovasc Surg; 1967 Mar; 53(3):335-40. PubMed ID: 6019145
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of ventricular fibrillation in coronary occlusion. Perfusion of coronary arteries with serum.
    DANESE C
    JAMA; 1962 Jan; 179():52-3. PubMed ID: 13883368
    [No Abstract]   [Full Text] [Related]  

  • 6. The initiation of ventricular tachycardia and fibrillation in experimental coronary artery occlusion.
    Carroll SE; Ahuja SP; Manning GW
    Am J Cardiol; 1965 Dec; 16(6):813-9. PubMed ID: 5846006
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of myocardial anoxia and plasma flow in the etiology of ventricular fibrillation.
    Charonis CG; Newcomb HL; Rogers LS
    Surg Forum; 1966; 17():192-4. PubMed ID: 5920905
    [No Abstract]   [Full Text] [Related]  

  • 8. Time course of vulnerability to fibrillation after experimental coronary occlusion.
    Burgess MJ; Abildskov JA; Millar K; Geddes JS; Green LS
    Am J Cardiol; 1971 Jun; 27(6):617-21. PubMed ID: 5088767
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) on ventricular fibrillation induced by coronary occlusion.
    Kaumann AJ; Aramendia P
    Acta Physiol Lat Am; 1966; 16(2):206-7. PubMed ID: 5918592
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventricular defibrillation in a patient with probable acute coronary occlusion.
    REAGAN LB; YOUNG KR; NICHOLSON JW
    Surgery; 1956 Mar; 39(3):482-6. PubMed ID: 13299002
    [No Abstract]   [Full Text] [Related]  

  • 11. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release.
    Axelrod PJ; Verrier RL; Lown B
    Am J Cardiol; 1975 Nov; 36(6):776-82. PubMed ID: 1199933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog.
    Blatt CM; Verrier RL; Lown B
    Am J Cardiol; 1977 Apr; 39(4):523-8. PubMed ID: 848436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Observations on its mode of action.
    Fearon RE
    Am J Cardiol; 1967 Aug; 20(2):222-8. PubMed ID: 4951347
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary occlusion before, during, and after strenuous exercise.
    Thompson PL; Lown B
    Cardiovasc Res; 1976 May; 10(3):385-8. PubMed ID: 954022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular vulnerability during acute coronary occlusion.
    Han J
    Am J Cardiol; 1969 Dec; 24(6):857-64. PubMed ID: 4188211
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil on ventricular rhythm during acute coronary occlusion.
    Fondacaro JD; Han J; Yoon MS
    Am Heart J; 1978 Jul; 96(1):81-6. PubMed ID: 655114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ventricular fibrillation with magnesium sulfate.
    Billman GE; Hoskins RS
    Eur J Pharmacol; 1988 Dec; 158(1-2):167-71. PubMed ID: 3220116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous heart rate, propranolol, and ischaemia-induced ventricular fibrillation in the dog.
    Reynolds RD; Calzadilla SV; Lee RJ
    Cardiovasc Res; 1978 Nov; 12(11):653-8. PubMed ID: 750078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of ventricular fibrillation after coronary artery occlusion via intracerebroventricular injections.
    Kirby DA; Johnson DA; Pinto J; Zhao S; Lown B
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H479-83. PubMed ID: 1510144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.